Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

47.96
+1.122.38%
Volume:9.10M
Turnover:438.15M
Market Cap:69.50B
PE:19.43
High:48.96
Open:46.27
Low:46.11
Close:46.84
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.61
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.79
PE(LYR):24.72

Loading ...

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

Boston Scientific Launches 2026 Global Restructuring Plan

TIPRANKS
·
Jul 28

Boston Scientific Launches Global Restructuring Plan with $700 Million-$800 Million in Charges

Reuters
·
Jul 28

Boston Scientific Corp - Estimates $700 Mln-$800 Mln Pre-Tax Charges, $500 Mln Annual Pre-Tax Expense Reduction - SEC Filing

THOMSON REUTERS
·
Jul 28

Boston Scientific Corp - Company Expects Headcount Reductions from Restructuring - SEC Filing

THOMSON REUTERS
·
Jul 28

NYSE Order Imbalance 902873.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 28

Boston Scientific’s FARAFLEX AFib Trial Steps Up the Pulsed Field Ablation Race

TIPRANKS
·
Jul 28

Boston Scientific Continues to See Competitive Pressures, Oppenheimer Says

MT Newswires Live
·
Jul 27

Movement Alert|Boston Scientific Rises 3.08% in Regular Trading, Pre-Earnings Optimism and Institutional Buy Ratings Support Shares

Market Focus
·
Jul 27

Boston Scientific is Maintained at Outperform by Oppenheimer

Dow Jones
·
Jul 27

Oppenheimer Trims Price Target on Boston Scientific to $85 From $90, Keeps Outperform Rating

MT Newswires Live
·
Jul 27

Inspire Medical Systems Appoints AtriCure CEO Michael Carrel to Board

Reuters
·
Jul 27

Boston Scientific price target lowered to $85 from $90 at Oppenheimer

TIPRANKS
·
Jul 27

Boston Scientific recommending some percutaneous catheters be removed, FDA says

TIPRANKS
·
Jul 25

Medical-device Stocks are in the Bargain Bin. 6 to Buy.

Dow Jones
·
Jul 24

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Earning Preview: Boston Scientific this quarter’s revenue is expected to increase by 9.63%, and institutional views are broadly bullish

Earnings Agent
·
Jul 22

Boston Scientific Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 22

Boston Scientific (BSX) Recalls Endoscopy Devices, Is The Stock A Bargain?

Simply Wall St.
·
Jul 17

Boston Scientific Corp. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 17